Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Polynovo ( (AU:PNV) ) just unveiled an update.
PolyNovo has appointed Arbor Vitae International LLC as its distributor for eight Balkan countries, extending its European commercial reach to an additional 22 million people through a cost-effective distribution model. The partnership, which capitalises on Arbor Vitae’s established network of key opinion leaders and its role in recent high-profile burn and trauma cases in the region, is expected to deepen surgeon adoption of NovoSorb products beyond acute burns into broader trauma and reconstructive indications, supporting PolyNovo’s capital-light European expansion strategy and strengthening its competitive positioning in advanced wound care.
The most recent analyst rating on (AU:PNV) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Polynovo stock, see the AU:PNV Stock Forecast page.
More about Polynovo
PolyNovo Limited is an Australia-based medical technology company focused on transforming the management of complex wounds through its proprietary NovoSorb biodegradable polymer platform. The company develops and commercialises products such as NovoSorb BTM, a synthetic dermal scaffold, and NovoSorb MTX, a fully synthetic dermal matrix, which are used in applications including acute burn care, trauma, and reconstructive surgery. With headquarters in Melbourne and operations in major markets including the United States, United Kingdom, India, Hong Kong, Singapore and other distributor-supported regions, PolyNovo has built a growing international footprint underpinned by revenue growth, profitability, multiple regulatory clearances and market leadership in several geographies.
YTD Price Performance: -17.48%
Average Trading Volume: 1,723,604
Technical Sentiment Signal: Sell
Current Market Cap: A$701.2M
For a thorough assessment of PNV stock, go to TipRanks’ Stock Analysis page.